AstraZeneca PLC (Germany) Today
| ZEGA Stock | EUR 63.00 0.50 0.80% |
Performance0 of 100
| Odds Of DistressLess than 9
|
AstraZeneca PLC is trading at 63.00 as of the 27th of November 2024. This is a 0.80 percent increase since the beginning of the trading day. The stock's lowest day price was 63.0. AstraZeneca PLC has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Equity ratings for AstraZeneca PLC are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 28th of October 2024 and ending today, the 27th of November 2024. Click here to learn more.
AstraZeneca PLC discovers, develops, and commercializes prescription medicines in the areas of oncology, cardiovascular, renal and metabolism, respiratory, autoimmunity, infection, neuroscience, and gastroenterology worldwide. AstraZeneca PLC was founded in 1992 and is headquartered in Cambridge, the United Kingdom. The company has 3.1 B outstanding shares. More on AstraZeneca PLC
Moving together with AstraZeneca Stock
Moving against AstraZeneca Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
AstraZeneca Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. AstraZeneca PLC's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding AstraZeneca PLC or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Drug Manufacturers - Major, Healthcare (View all Sectors) |
AstraZeneca PLC (ZEGA) is traded on Frankfurt Exchange in Germany and employs 83,500 people. The company currently falls under 'Mega-Cap' category with a current market capitalization of 194.57 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate AstraZeneca PLC's market, we take the total number of its shares issued and multiply it by AstraZeneca PLC's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. AstraZeneca PLC operates under Healthcare sector and is part of Drug Manufacturers - Major industry. The entity has 3.1 B outstanding shares.
AstraZeneca PLC has accumulated about 6.25 B in cash with 9.81 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.38.
Check AstraZeneca PLC Probability Of Bankruptcy
Ownership AllocationAstraZeneca PLC holds a total of 3.1 Billion outstanding shares. Almost 82.24 percent of AstraZeneca PLC outstanding shares are held by general public with 0.04 (percent) owned by insiders and only 17.72 % by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check AstraZeneca Ownership Details
AstraZeneca PLC Risk Profiles
Although AstraZeneca PLC's alpha and beta are two of the key measurements used to evaluate AstraZeneca PLC's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 1.21 | |||
| Standard Deviation | 1.78 | |||
| Variance | 3.16 | |||
| Risk Adjusted Performance | (0.12) |
AstraZeneca Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in AstraZeneca PLC without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Instant Ratings Now
Instant RatingsDetermine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |
| All Next | Launch Module |
AstraZeneca PLC Corporate Management
Elected by the shareholders, the AstraZeneca PLC's board of directors comprises two types of representatives: AstraZeneca PLC inside directors who are chosen from within the company, and outside directors, selected externally and held independent of AstraZeneca. The board's role is to monitor AstraZeneca PLC's management team and ensure that shareholders' interests are well served. AstraZeneca PLC's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, AstraZeneca PLC's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Marc Dunoyer | CEO Officer | Profile | |
| Chris Sheldon | Head Relations | Profile | |
| Pam Cheng | EVP Board | Profile | |
| MBA DVM | CEO Director | Profile | |
| Gonzalo Vina | Head Relations | Profile | |
| Aradhana MD | CFO Director | Profile | |
| Menelas Pangalos | EVP Board | Profile |
Other Information on Investing in AstraZeneca Stock
AstraZeneca PLC financial ratios help investors to determine whether AstraZeneca Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in AstraZeneca with respect to the benefits of owning AstraZeneca PLC security.